TARS Tarsus Pharmaceuticals, Inc. - Common Stock
$70,74
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$48–$84
63% of range
Analystenbewertung
STRONG BUY
15 analysts
Kursziel
$95
+34% upside
P/E (TTM)
-45.0
ROE
-19.7%
Nettogewinnmarge
-14.7%
TARS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$70.74
Marktkapitalisierung
$3.04B
P/E (TTM)
-45.0
EPS (TTM)
$-1.59
Umsatz (TTM)
$451M
Dividendenrendite
—
ROE
-19.7%
Verschuldungsgrad
0.2
52W-Spanne
$48 – $84
TARS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$451M
2020-12-31
→
2025-12-31
EPS
$-1.59
2020-12-31
→
2025-12-31
Freier Cashflow
$-22M
2020-12-31
→
2025-12-31
Margen
-14.7%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TARS
Peer-Median
P/E (TTM)
-45.0
29.4
P/S (TTM) (K/V (TTM))
6.7
4.9
P/B (K/B)
8.9
6.5
EV / EBITDA
-38.0
—
Price / FCF (Kurs / FCF)
-136.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TARS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-15.7%
—
Net Profit Margin (Nettogewinnmarge)
-14.7%
-9.0%
ROA
-14.1%
-8.2%
ROE
-19.7%
-19.4%
ROIC
-17.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TARS
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.2
—
Current Ratio (Liquiditätsgrad)
3.9
3.6
Quick Ratio
3.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TARS
Peer-Median
Revenue YoY (Umsatz YoY)
146.7%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
159.5%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TARS
Peer-Median
TARS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 7 46,7%
- Kauf 7 46,7%
- Halten 1 6,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
7 Analysten · 2026-08-19
Median
$99.00
Mittelwert
$94.86
← Unter allen Zielen
$70.74
Tief
$84.00
Hoch
$104.00
Median-Ziel
$99.00
+39,9%
Mittelwert-Ziel
$94.86
+34,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.49 | $-0.20 | -0.29% |
| 31. März 2026 | $-0.16 | $-0.38 | 0.22% |
| 31. Dezember 2025 | $-0.20 | $-0.10 | -0.10% |
| 30. September 2025 | $-0.30 | $-0.36 | 0.06% |
| 30. Juni 2025 | $-0.48 | $-0.41 | -0.07% |
| 31. März 2025 | $-0.64 | $-0.75 | 0.11% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
| NKTR | $862M | -4.3 | -43.9% | -297.1% | -500.1% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $451M | $183M | $17M | $26M | $57M | $0 | |
| R&D Expense | $64M | $53M | $50M | $43M | $42M | $19M | |
| SG&A Expense | $427M | $237M | $109M | $45M | $25M | $8M | |
| Operating Expenses | $522M | $304M | $161M | $89M | $69M | $27M | |
| Operating Income | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M | |
| Interest Expense | · | · | $3M | $2M | $0 | · | |
| Other Non-op | $-202.0K | $-206.0K | $274.0K | $86.0K | $-73.0K | $0 | |
| Pretax Income | $-64M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Income Tax | $2M | $0 | $0 | $-4.0K | $55.0K | $1.0K | |
| Net Income | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| EPS (Basic) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| EPS (Diluted) | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 | $-4.32 | |
| Shares (Basic) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| Shares (Diluted) | 41,784,014 | 37,604,538 | 29,383,276 | 24,619,700 | 20,554,086 | 6,207,367 | |
| EBITDA | $-71M | $-121M | $-143M | $-63M | $-12M | $-27M |
Bilanz 26
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $184M | $95M | $225M | $72M | $171M | $168M | |
| Short-term Investments | $234M | $197M | $2M | $145M | $483.0K | $0 | |
| Receivables | $85M | $47M | $17M | $0 | $0 | $0 | |
| Inventory | $4M | $3M | $3M | $0 | · | · | |
| Prepaid Expense | $13M | $15M | $8M | $5M | $4M | $2M | |
| Current Assets | $523M | $357M | $256M | $225M | $176M | $171M | |
| PP&E (Net) | $12M | $2M | $1M | $957.0K | $755.0K | $548.0K | |
| PP&E (Gross) | $14M | $4M | $3M | $2M | $976.0K | $682.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $546.0K | $221.0K | $134.0K | |
| Intangibles | $7M | $8M | $4M | $0 | · | · | |
| Other Non-current Assets | $2M | $999.0K | $2M | $585.0K | $1M | $81.0K | |
| Total Assets | $562M | $377M | $265M | $228M | $179M | $172M | |
| Accounts Payable | $16M | $9M | · | · | · | · | |
| Current Liabilities | $136M | $81M | $37M | $15M | $11M | $5M | |
| Capital Leases | $11M | $0 | $2M | $52.0K | $585.0K | $549.0K | |
| Other Non-current Liabilities | $11M | $0 | $2M | $100.0K | $699.0K | $605.0K | |
| Total Liabilities | $219M | $152M | $69M | $35M | $12M | $6M | |
| Long-term Debt | $72M | $72M | $30M | $19M | · | · | |
| Total Debt | $72M | $72M | $30M | $19M | · | · | |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $770M | $585M | $442M | $302M | $213M | $199M | |
| Retained Earnings | $-427M | $-360M | $-245M | $-109M | $-47M | $-33M | |
| AOCI | $381.0K | $179.0K | $-2.0K | $-74.0K | $0 | · | |
| Stockholders' Equity | $343M | $225M | $197M | $193M | $167M | $166M | |
| Liabilities + Equity | $562M | $377M | $265M | $228M | $179M | $172M | |
| Shares Outstanding | 42,553,931 | 38,349,826 | 34,211,190 | 26,727,458 | 20,698,737 | 20,323,201 |
Cashflow 12
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $42M | $28M | $20M | $13M | $8M | $839.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Amort. of Intangibles | $961.0K | $540.0K | $133.0K | $0 | · | · | |
| Operating Cash Flow | $-12M | $-83M | $-117M | $-49M | $4M | $-21M | |
| CapEx | $10M | $2M | $2M | $506.0K | $586.0K | $456.0K | |
| Investing Cash Flow | $-42M | $-199M | $141M | $-145M | $-586.0K | $-456.0K | |
| Debt Issued | $0 | $75M | $10M | $20M | · | · | |
| Net Debt Issued | $0 | $75M | · | · | · | · | |
| Financing Cash Flow | $143M | $155M | $130M | $94M | $21.0K | $132M | |
| Net Change in Cash | $89M | $-128M | $153M | $-100M | $3M | $110M | |
| Free Cash Flow | $-22M | $-85M | $-119M | $-50M | $3M | $-22M | |
| Levered FCF | · | · | $-122M | $-52M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| Net Margin | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | · | |
| Pretax Margin | -14.3% | -63.2% | -778.9% | -240.5% | -24.1% | · | |
| EBITDA Margin | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | · | |
| ROA | -14.1% | -36.0% | -55.1% | -30.5% | -7.9% | -23.3% | |
| ROE | -19.7% | -50.0% | -66.2% | -31.4% | -8.0% | -36.2% | |
| ROIC | -17.6% | -40.7% | -63.1% | -29.5% | -7.3% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 | 31.7 | |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 | 31.2 | |
| Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| LT Debt / Equity | 0.2 | 0.3 | 0.2 | 0.1 | · | · | |
| Interest Coverage | · | · | -42.8 | -28.5 | · | · |
Effizienz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.1 | 0.1 | 0.3 | · | |
| Receivables Turnover | 6.8 | 5.8 | 2.1 | · | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 146.7% | 948.6% | -32.4% | -54.7% | · | · | |
| Revenue CAGR 3Y | 159.5% | 47.5% | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $451M | $183M | $17M | $26M | $57M | $0 | |
| Net Income TTM | $-66M | $-116M | $-136M | $-62M | $-14M | $-27M | |
| Market Cap | $3.48B | $2.12B | $693M | $392M | $466M | $840M | |
| Enterprise Value | $3.14B | $1.90B | $495M | $194M | · | · | |
| P/E | -51.5 | -18.0 | -4.4 | -5.8 | -33.6 | -9.6 | |
| P/S | 7.7 | 11.6 | 39.7 | 15.2 | 8.2 | · | |
| P/B | 10.1 | 9.5 | 3.5 | 2.0 | 2.8 | 5.1 | |
| P / Tangible Book | 10.4 | 9.8 | 3.6 | 2.0 | 2.8 | 5.1 | |
| P / Cash Flow | -279.8 | -25.6 | -5.9 | -8.0 | 124.3 | -39.7 | |
| P / FCF | -156.2 | -25.1 | -5.8 | -7.9 | 147.3 | -38.9 | |
| EV / EBITDA | -44.2 | -15.8 | -3.5 | -3.1 | · | · | |
| EV / FCF | -140.7 | -22.5 | -4.2 | -3.9 | · | · | |
| EV / Revenue | 7.0 | 10.4 | 28.4 | 7.5 | · | · | |
| Earnings Yield | -1.9% | -5.5% | -22.8% | -17.2% | -3.0% | -10.4% |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $174M | $162M | $152M | $119M | $103M | $78M | $66M | $48M | $41M | $28M | $13M | $2M | $0 | $2M | $10M | $0 | |
| Cost of Revenue | $12M | $9M | · | · | $6M | $5M | · | · | · | · | · | · | $0 | $0 | · | $0 | |
| R&D Expense | $31M | $22M | $18M | $16M | $16M | $14M | $17M | $12M | $12M | $12M | $13M | $12M | $13M | $12M | $10M | $11M | |
| SG&A Expense | $151M | $136M | $131M | $109M | $103M | $85M | $69M | $58M | $59M | $52M | $43M | $30M | $20M | $15M | $15M | $12M | |
| Operating Expenses | $194M | $168M | $160M | $133M | $125M | $105M | $91M | $73M | $74M | $65M | $58M | $43M | $33M | $27M | $25M | $23M | |
| Operating Income | $-20M | $-6M | $-8M | $-15M | $-22M | $-26M | $-24M | $-25M | $-33M | $-38M | $-44M | $-41M | $-33M | $-25M | $-15M | $-23M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $983.0K | · | $858.0K | $815.0K | $684.0K | · | $633.0K | |
| Other Non-op | $-281.0K | $-87.0K | $-74.0K | $98.0K | $-145.0K | $-81.0K | $-27.0K | $67.0K | $-65.0K | $-181.0K | $363.0K | $-48.0K | $-47.0K | $6.0K | $-50.0K | $-7.0K | |
| Income Tax | $3M | $2M | · | · | $0 | $0 | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $-5.0K | |
| Net Income | $-19M | $-7M | $-8M | $-13M | $-20M | $-25M | $-23M | $-23M | $-33M | $-36M | $-42M | $-39M | $-31M | $-23M | $-14M | $-23M | |
| EPS (Basic) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| EPS (Diluted) | $-0.43 | $-0.16 | $-0.17 | $-0.30 | $-0.48 | $-0.64 | $-0.57 | $-0.61 | $-0.88 | $-1.01 | $-1.29 | $-1.28 | $-1.17 | $-0.88 | $-0.46 | $-0.84 | |
| Shares (Basic) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| Shares (Diluted) | 43,393,643 | 42,956,973 | -82,529,514 | 42,607,717 | 42,360,452 | 39,345,359 | -73,901,318 | 38,381,968 | 37,823,233 | 35,300,655 | -54,796,920 | 30,622,440 | 26,815,733 | 26,742,023 | -47,085,429 | 26,662,374 | |
| EBITDA | $-20M | $-6M | · | $-15M | $-22M | $-26M | · | $-25M | $-33M | $-38M | · | $-41M | $-33M | $-25M | · | $-23M |
Bilanz 26
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $102M | $184M | $113M | $97M | $176M | $95M | $176M | $181M | $194M | · | $227M | $107M | $66M | · | $169M | |
| Short-term Investments | $245M | $287M | $234M | $289M | $284M | $232M | $197M | $141M | $142M | $105M | · | $20M | $71M | $135M | · | $57M | |
| Receivables | $96M | $100M | $85M | $73M | $58M | $62M | $47M | $29M | $30M | $30M | · | $5M | · | $2M | · | $17.0K | |
| Inventory | $4M | $5M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $4M | · | $15.0K | · | · | · | · | |
| Prepaid Expense | $10M | $27M | $13M | $22M | $29M | $6M | $15M | $7M | $6M | $7M | · | $6M | $5M | $5M | · | $3M | |
| Current Assets | $562M | $537M | $523M | $502M | $474M | $481M | $357M | $357M | $363M | $341M | · | $259M | $183M | $209M | · | $234M | |
| PP&E (Net) | $20M | $18M | $12M | $6M | $3M | $3M | $2M | $2M | $2M | $1M | · | $2M | $2M | $1M | · | $951.0K | |
| PP&E (Gross) | $22M | $20M | $14M | $8M | $6M | $5M | $4M | $4M | $4M | $3M | · | $3M | $2M | $2M | · | $1M | |
| Accum. Depreciation | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $1M | · | $1M | $832.0K | $649.0K | · | $448.0K | |
| Intangibles | $7M | $7M | $7M | $8M | $8M | $8M | $8M | $9M | $4M | $4M | · | $4M | · | · | · | · | |
| Other Non-current Assets | $660.0K | $715.0K | $2M | $1M | $1M | $616.0K | $999.0K | $888.0K | $846.0K | $1M | · | $1M | $1M | $529.0K | · | $583.0K | |
| Total Assets | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Accounts Payable | $40M | $24M | $16M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $176M | $144M | $136M | $117M | $90M | $86M | $81M | $66M | $52M | $43M | · | $23M | $15M | $13M | · | $14M | |
| Capital Leases | $16M | $16M | $11M | $10M | $0 | $0 | · | $1M | $1M | $2M | · | $2M | $2M | · | · | $169.0K | |
| Other Non-current Liabilities | $16M | $16M | $11M | $10M | · | · | $0 | $1M | $1M | $2M | · | $2M | $2M | $40.0K | · | $209.0K | |
| Total Liabilities | $264M | $232M | $219M | $199M | $162M | $158M | $152M | $139M | $125M | $74M | · | $55M | $41M | $38M | · | $34M | |
| Long-term Debt | $73M | $73M | $72M | $72M | $72M | $72M | $72M | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Total Debt | $73M | $73M | · | $72M | $72M | $72M | · | $72M | $72M | $30M | · | $30M | $25M | $25M | · | $19M | |
| Common Stock | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Paid-in Capital | $799M | $783M | $770M | $753M | $738M | $728M | $585M | $574M | $566M | $556M | · | $416M | $311M | $306M | · | $298M | |
| Retained Earnings | $-452M | $-434M | $-427M | $-418M | $-406M | $-385M | $-360M | $-337M | $-314M | $-280M | · | $-203M | $-164M | $-132M | · | $-95M | |
| AOCI | $-557.0K | $-298.0K | $381.0K | $289.0K | $39.0K | $85.0K | $179.0K | $346.0K | $-176.0K | $-63.0K | · | $-8.0K | $-23.0K | $-70.0K | · | $-10.0K | |
| Stockholders' Equity | $347M | $349M | $343M | $335M | $333M | $342M | $225M | $237M | $252M | $275M | $197M | $214M | $148M | $173M | $193M | $203M | |
| Liabilities + Equity | $611M | $581M | $562M | $535M | $495M | $501M | $377M | $376M | $377M | $349M | · | $268M | $189M | $211M | · | $236M | |
| Shares Outstanding | 43,271,347 | 43,021,312 | 42,553,931 | 42,447,882 | 42,210,972 | 41,995,537 | 38,349,826 | 38,196,072 | 38,030,385 | 37,749,468 | 34,211,190 | 33,104,087 | 26,899,572 | 26,800,512 | 26,727,458 | 26,671,812 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $12M | $14M | $12M | $8M | $7M | $7M | $7M | $7M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | |
| Amort. of Intangibles | $200.0K | $240.0K | $321.0K | $200.0K | $200.0K | $240.0K | $240.0K | $100.0K | $100.0K | $100.0K | $133.0K | $0 | $0 | $0 | $0 | · | |
| Operating Cash Flow | $61M | $-25M | $19M | $18M | $-29M | $-21M | $-22M | $-9M | $-14M | $-38M | $-39M | $-32M | $-24M | $-22M | $-11M | $-19M | |
| CapEx | $4M | $6M | $6M | $2M | $1M | $590.0K | $72.0K | $282.0K | $1M | $174.0K | $0 | $375.0K | $787.0K | $340.0K | $127.0K | $96.0K | |
| Investing Cash Flow | $38M | $-59M | $49M | $-5M | $-52M | $-35M | $-60M | $3M | $-41M | $-102M | $18M | $47M | $64M | $11M | $-87M | $-57M | |
| Debt Issued | · | · | $0 | $0 | · | · | $0 | $0 | $75M | $0 | $0 | $5M | $0 | $5M | $0 | $0 | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $5M | · | · | |
| Stock Issued | $0 | $0 | · | $0 | $-354.0K | $135M | · | $-43.0K | $-274.0K | $99M | · | $99M | $0 | $0 | · | $-218.0K | |
| Net Stock Activity | · | $0 | · | · | · | $135M | · | · | · | $99M | · | · | · | · | · | · | |
| Financing Cash Flow | $3M | $1M | $2M | $3M | $2M | $137M | $3M | $639.0K | $42M | $109M | $20M | $105M | $510.0K | $5M | $264.0K | $-136.0K | |
| Net Change in Cash | $102M | $-82M | $71M | $16M | $-79M | $81M | $-79M | $-5M | $-13M | $-31M | $-2M | $120M | $41M | $-6M | $-98M | $-76M | |
| Taxes Paid | $3M | $2M | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-30M | · | · | · | $-21M | · | · | · | $-38M | · | · | · | $-22M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| Net Margin | -10.7% | -4.3% | · | -10.6% | -19.8% | -32.1% | · | -48.7% | -81.6% | -129.4% | · | -2092.4% | · | · | · | · | |
| EBITDA Margin | -11.5% | -3.8% | · | -12.2% | -21.6% | -33.6% | · | -52.3% | -81.6% | -136.5% | · | -2187.9% | · | · | · | · | |
| ROA | -3.4% | -1.3% | · | -2.8% | -4.7% | -5.9% | · | -7.3% | -11.8% | -12.8% | · | -15.5% | -14.2% | -11.9% | · | -10.5% | |
| ROE | -5.5% | -2.0% | · | -4.4% | -7.0% | -8.1% | · | -10.4% | -16.7% | -15.9% | · | -18.8% | -17.0% | -14.5% | · | -11.8% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 3.7 | · | 4.3 | 5.3 | 5.6 | · | 5.4 | 7.0 | 8.0 | · | 11.2 | 12.4 | 15.7 | · | 16.4 | |
| Quick Ratio | 3.1 | 3.4 | · | 4.1 | 4.9 | 5.4 | · | 5.3 | 6.8 | 7.7 | · | 10.8 | 12.1 | 15.4 | · | 15.9 | |
| Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -38.3 | · | -47.7 | -40.3 | -36.5 | · | -36.2 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | · | · | · | 0.0 | |
| Inventory Turnover | 2.9 | 2.6 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 2.3 | 2.0 | · | 2.3 | 2.3 | 1.7 | · | 2.8 | 2.8 | 1.7 | · | 0.7 | · | · | · | 0.0 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $557M | $462M | · | $348M | $270M | $195M | · | $118M | $70M | $32M | · | $4M | $18M | $18M | · | $17M | |
| Net Income TTM | $-58M | $-65M | · | $-81M | $-102M | $-118M | · | $-132M | $-140M | $-130M | · | $-117M | $-83M | $-72M | · | $-64M | |
| Market Cap | $2.72B | $3.02B | · | $2.52B | $1.71B | $2.16B | · | $1.26B | $1.03B | $1.37B | · | $588M | $486M | $337M | · | $457M | |
| Enterprise Value | $2.35B | $2.70B | · | $2.19B | $1.40B | $1.82B | · | $1.01B | $782M | $1.10B | · | $371M | $332M | $160M | · | $249M | |
| P/E | -45.9 | -44.4 | · | -29.3 | -15.5 | -16.4 | · | -8.7 | -6.3 | -8.4 | · | -4.3 | -5.8 | -4.3 | · | -6.1 | |
| P/S | 4.9 | 6.5 | · | 7.3 | 6.3 | 11.1 | · | 10.6 | 14.7 | 42.9 | · | 134.6 | 27.3 | 18.4 | · | 26.8 | |
| P/B | 7.9 | 8.6 | · | 7.5 | 5.1 | 6.3 | · | 5.3 | 4.1 | 5.0 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Tangible Book | 8.0 | 8.8 | · | 7.7 | 5.3 | 6.5 | · | 5.5 | 4.2 | 5.1 | · | 2.8 | 3.3 | 1.9 | · | 2.3 | |
| P / Cash Flow | · | -122.4 | · | · | · | -104.5 | · | · | · | -36.3 | · | · | · | -15.3 | · | · | |
| P / FCF | · | -99.0 | · | · | · | -101.6 | · | · | · | -36.1 | · | · | · | -15.1 | · | · | |
| EV / EBITDA | -117.9 | -441.3 | · | -150.9 | -63.2 | -69.3 | · | -40.2 | -23.5 | -29.3 | · | -9.1 | -10.1 | -6.4 | · | -10.9 | |
| EV / FCF | · | -88.7 | · | · | · | -85.7 | · | · | · | -29.1 | · | · | · | -7.2 | · | · | |
| EV / Revenue | 4.2 | 5.9 | · | 6.3 | 5.2 | 9.3 | · | 8.5 | 11.1 | 34.5 | · | 84.9 | 18.7 | 8.7 | · | 14.6 | |
| Earnings Yield | -2.2% | -2.2% | · | -3.4% | -6.4% | -6.1% | · | -11.5% | -16.0% | -11.9% | · | -23.5% | -17.3% | -23.4% | · | -16.5% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $451M | $183M | $17M | $26M | $57M |
| Betriebsgewinnmarge % | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% |
| Nettoergebnis | $-66M | $-116M | $-136M | $-62M | $-14M |
| Verwässerte EPS | $-1.59 | $-3.07 | $-4.62 | $-2.52 | $-0.67 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | 0.3 | 0.2 | 0.1 | — |
| Liquiditätsgrad | 3.9 | 4.4 | 6.9 | 14.6 | 15.3 |
| Quick Ratio | 3.7 | 4.2 | 6.6 | 14.1 | 15.0 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-22M | $-85M | $-119M | $-50M | $3M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 281 Einreicher · $2.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (-4 vs. Vorquartal) | 32 (+1 vs. Vorquartal) | 102 (+14 vs. Vorquartal) | 75 (+2 vs. Vorquartal) | +3.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Deep Track Capital, LP | $230.786.378 | 3.666.768 | 10,62% | Aktien |
| RTW INVESTMENTS, LP | $211.293.293 | 3.357.059 | 9,73% | Aktien |
| Paradigm Biocapital Advisors LP | $174.699.348 | 2.775.649 | 8,04% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $112.855.448 | 1.793.064 | 5,19% | Aktien |
| TANG CAPITAL MANAGEMENT LLC | $98.706.662 | 1.568.266 | 4,54% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $89.823.185 | 1.427.124 | 4,13% | Aktien |
| JENNISON ASSOCIATES LLC | $85.924.054 | 1.365.174 | 3,95% | Aktien |
| STATE STREET CORP | $67.531.536 | 1.072.951 | 3,11% | Aktien |
| Vestal Point Capital, LP | $66.087.000 | 1.050.000 | 3,04% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $60.171.216 | 955.795 | 2,77% | Aktien |
| Assenagon Asset Management S.A. | $59.635.335 | 947.495 | 2,74% | Aktien |
| BANK OF AMERICA CORP /DE/ | $57.474.227 | 913.159 | 2,65% | Aktien |
| Frazier Life Sciences Management, L.P. | $45.860.853 | 728.644 | 2,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $39.934.864 | 634.491 | 1,84% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $38.222.000 | 607.272 | 1,76% | Aktien |
| Clearbridge Investments, LLC | $34.578.420 | 549.387 | 1,59% | Aktien |
| TORONTO DOMINION BANK | $32.115.324 | 510.253 | 1,48% | Aktien |
| TimesSquare Capital Management, LLC | $27.259.589 | 388.590 | 1,25% | Aktien |
| Caption Management, LLC | $25.805.400 | 410.000 | 1,19% | Verkaufsoption |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $24.240.523 | 385.137 | 1,12% | Aktien |
| FMR LLC | $22.739.718 | 361.292 | 1,05% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $21.137.392 | 335.834 | 0,97% | Aktien |
| Tri Locum Partners LP | $20.665.720 | 328.340 | 0,95% | Aktien |
| MPM BIOIMPACT LLC | $20.267.121 | 322.007 | 0,93% | Aktien |
| Driehaus Capital Management LLC | $19.988.233 | 317.576 | 0,92% | Aktien |
| LOOMIS SAYLES & CO L P | $19.924.161 | 316.558 | 0,92% | Aktien |
| Squarepoint Ops LLC | $18.619.163 | 295.824 | 0,86% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $18.019.030 | 286.289 | 0,83% | Aktien |
| Artisan Partners Limited Partnership | $17.931.543 | 284.899 | 0,83% | Aktien |
| D. E. Shaw & Co., Inc. | $17.770.605 | 282.342 | 0,82% | Aktien |
| Rock Springs Capital Management LP | $17.439.856 | 277.087 | 0,80% | Aktien |
| Ensign Peak Advisors, Inc | $16.911.726 | 268.696 | 0,78% | Aktien |
| CITADEL ADVISORS LLC | $15.214.927 | 241.737 | 0,70% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $12.690.215 | 201.624 | 0,58% | Aktien |
| MACKENZIE FINANCIAL CORP | $12.048.478 | 191.428 | 0,55% | Aktien |
| JANE STREET GROUP, LLC | $11.964.894 | 190.100 | 0,55% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.864.190 | 188.500 | 0,55% | Kaufoption |
| Cutter Capital Management, LP | $10.530.850 | 205.000 | 0,48% | Aktien |
| Parkman Healthcare Partners LLC | $9.441.000 | 150.000 | 0,43% | Aktien |
| Seven Fleet Capital Management LP | $7.909.873 | 117.067 | 0,36% | Aktien |
| Caption Management, LLC | $7.596.858 | 120.700 | 0,35% | Aktien |
| Jefferies Financial Group Inc. | $7.477.901 | 118.810 | 0,34% | Aktien |
| FIRST TRUST ADVISORS LP | $7.415.024 | 117.811 | 0,34% | Aktien |
| Qube Research & Technologies Ltd | $7.323.887 | 116.363 | 0,34% | Aktien |
| Woodline Partners LP | $6.321.882 | 100.443 | 0,29% | Aktien |
| Cormorant Asset Management, LP | $6.294.000 | 100.000 | 0,29% | Aktien |
| Schonfeld Strategic Advisors LLC | $6.284.243 | 99.845 | 0,29% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $6.224.766 | 98.900 | 0,29% | Aktien |
| XTX Topco Ltd | $5.987.482 | 95.130 | 0,28% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $5.725.589 | 90.969 | 0,26% | Aktien |
| HighVista Strategies LLC | $5.479.557 | 87.060 | 0,25% | Aktien |
| Sands Capital Alternatives, LLC | $5.349.900 | 85.000 | 0,25% | Aktien |
| COMMONWEALTH EQUITY SERVICES, LLC | $5.028.170 | 79.888 | 0,23% | Aktien |
| JANUS HENDERSON GROUP PLC | $4.801.294 | 68.438 | 0,22% | Aktien |
| Cubist Systematic Strategies, LLC | $4.395.129 | 73.955 | 0,20% | Aktien |
| Freestone Grove Partners LP | $4.304.404 | 68.389 | 0,20% | Aktien |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | $4.268.906 | 67.825 | 0,20% | Aktien |
| CITIGROUP INC | $4.083.610 | 64.881 | 0,19% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $3.877.104 | 61.600 | 0,18% | Aktien |
| Emerald Investment Advisers, LLC | $3.760.476 | 59.747 | 0,17% | Aktien |
| Swiss National Bank | $3.759.595 | 59.733 | 0,17% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.756.322 | 59.681 | 0,17% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $3.579.684 | 51.029 | 0,16% | Aktien |
| Eversept Partners, LP | $3.506.387 | 55.710 | 0,16% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $3.440.993 | 54.671 | 0,16% | Aktien |
| BlackRock, Inc. | $3.375.850 | 53.636 | 0,16% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.375.850 | 53.636 | 0,16% | Aktien |
| RHUMBLINE ADVISERS | $3.318.058 | 52.718 | 0,15% | Aktien |
| TORONTO DOMINION BANK | $2.958.180 | 47.000 | 0,14% | Kaufoption |
| E. Ohman J:or Asset Management AB | $2.952.403 | 42.087 | 0,14% | Aktien |
| Cinctive Capital Management LP | $2.906.695 | 46.182 | 0,13% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.832.300 | 45.000 | 0,13% | Verkaufsoption |
| Trexquant Investment LP | $2.778.927 | 44.152 | 0,13% | Aktien |
| Voleon Capital Management LP | $2.731.911 | 43.405 | 0,13% | Aktien |
| ALPS ADVISORS INC | $2.729.393 | 43.365 | 0,13% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.644.304 | 37.695 | 0,12% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $2.628.311 | 41.759 | 0,12% | Aktien |
| Odyssean, LLC | $2.605.338 | 41.394 | 0,12% | Aktien |
| PFM Health Sciences, LP | $2.554.042 | 40.579 | 0,12% | Aktien |
| Vontobel Holding Ltd. | $2.517.600 | 40.000 | 0,12% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $2.473.731 | 39.303 | 0,11% | Aktien |
| Baird Financial Group, Inc. | $2.448.240 | 38.898 | 0,11% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.404.182 | 38.198 | 0,11% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.268.232 | 36.038 | 0,10% | Aktien |
| ORBIMED ADVISORS LLC | $2.239.468 | 35.581 | 0,10% | Aktien |
| BARCLAYS PLC | $2.212.088 | 35.146 | 0,10% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.095.273 | 33.290 | 0,10% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $2.071.230 | 32.908 | 0,10% | Aktien |
| PDT Partners, LLC | $2.032.458 | 32.292 | 0,09% | Aktien |
| Ikarian Capital, LLC | $1.961.588 | 31.166 | 0,09% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.888.200 | 30.000 | 0,09% | Kaufoption |
| OCCUDO QUANTITATIVE STRATEGIES LP | $1.866.737 | 29.659 | 0,09% | Aktien |
| VANGUARD GROUP INC | $1.698.846 | 20.748 | 0,08% | Aktien |
| J. Goldman & Co LP | $1.686.792 | 26.800 | 0,08% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.654.755 | 26.291 | 0,08% | Aktien |
| AlphaQuest LLC | $1.571.523 | 19.193 | 0,07% | Aktien |
| Entropy Technologies, LP | $1.547.254 | 24.583 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $1.541.589 | 24.493 | 0,07% | Aktien |
| Lido Advisors, LLC | $1.530.827 | 24.322 | 0,07% | Aktien |
| Atika Capital Management LLC | $1.468.642 | 23.334 | 0,07% | Aktien |
Unternehmensinsider 21 Insider · 9 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Bobak R. Azamian | President/CEO and Board Chair | 17. Juni 2026 S | 847.991 | 0 | 2 | $-615.489 |
| Jeffrey S Farrow | Chief Financial Officer and Chief Strategy Officer | 15. Juni 2026 M | 56.801 | 0 | 4 | $-1.317.002 |
| Leonard M. Greenstein | Chief Financial Officer | 8. März 2023 A | — | 0 | 0 | $0 |
| Seshadri Neervannan | Chief Operating Officer | 15. März 2023 M | 56.577 | 0 | 0 | $0 |
| Aziz Mottiwala | Chief Commercial Officer | 8. Juni 2023 S | 48.086 | 0 | 0 | $0 |
| Bryan Wahl | General Counsel | 15. März 2023 M | 18.176 | 0 | 0 | $0 |
| Dianne C. Whitfield | Chief Human Resources Officer | 15. März 2023 M | 12.872 | 0 | 0 | $0 |
| Mark J. Holdbrook | V.P., Clinical Affairs | 15. März 2023 M | 3.577 | 0 | 0 | $0 |
| Jose M. Trevejo | Chief Medical Officer | 15. März 2023 M | 8.654 | 0 | 0 | $0 |
| Katherine Goodrich | Direktor | 25. Juni 2026 A | 2.233 | 0 | 1 | $-183.384 |
| Andrew D. Goldberg | Direktor | 25. Juni 2026 A | 19.654 | 0 | 0 | $0 |
| Scott W Morrison | Direktor | 25. Juni 2026 A | 7.638 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Direktor | 25. Juni 2026 A | 11.654 | 0 | 0 | $0 |
| William J Link PHD | Direktor | 25. Juni 2026 A | 106.786 | 0 | 10 | $-3.500.993 |
| Wendy L Yarno | Direktor | 25. Juni 2026 A | 16.654 | 0 | 0 | $0 |
| David E I Pyott | Direktor | 25. Juni 2026 A | 1.383 | 0 | 0 | $0 |
| Michael Ackermann | Direktor | 15. Juni 2022 M | 1.208.273 | 0 | 0 | $0 |
| Elizabeth Yeu Lin | Direktor | 31. Dezember 2021 A | — | 0 | 0 | $0 |
| Rosemary A Crane | Direktor | 11. August 2021 A | — | 0 | 0 | $0 |
| Jason E. Tester | Direktor | 15. Juni 2021 A | 1.920.933 | 0 | 0 | $0 |
| Horowitz Limited Partnership VIII | 10%-Eigentümer | 20. Oktober 2020 C | 66.172 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Horowitz Limited Partnership VIII, Horowitz Management, Inc., Adam S. Horowitz Revocable Trust, Jason E. Tester | 30. Oktober 2020 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 50 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,69% | 210.454 SH | 8. August 2026 | Täglich |
| SBIO · ALPS ETF Trust | 1,61% | 43.870 NS | 31. Mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,25% | 11.632 NS | 30. April 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,22% | 2.469 NS | 30. April 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,19% | 29.463 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 0,57% | 141.498 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,40% | 66.585 NS | 30. April 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,24% | 3.915 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 0,20% | 295.665 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,19% | 2.342 SH | 8. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,18% | 712 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,17% | 379.742 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,16% | 44.912 SH | 8. August 2026 | Täglich |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,16% | 29.611 NS | 30. April 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,13% | 1.124 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,13% | 1.573 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,12% | 19.431 NS | 31. Mai 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 40.784 NS | 30. April 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,10% | 1.305 NS | 30. April 2026 | N-PORT |
| SMLF · iShares Trust | 0,10% | 65.431 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,10% | 11.160 NS | 30. April 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 1.067.848 SH | 8. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 6.209 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 241.028 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,08% | 12.043 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,08% | 17.152 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,06% | 1.862 NS | 31. Mai 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 21.718 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,05% | 187.238 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,04% | 1.688 SH | 8. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,04% | 1.565 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,03% | 1.456 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 14.864 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 455.389 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 89.651 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 1.476 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 9.169 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,02% | 6.187 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 1.892 SH | 8. August 2026 | Täglich |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.590 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 37 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 13.644 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 54.981 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 9.881 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 23.482 NS | 31. Mai 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 636 NS | 30. April 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,00% | 18 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.295.901 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.359 SH | 8. August 2026 | Täglich |
| FTLS · First Trust Exchange-Traded Fund III | -0,03% | -12.099 NS | 30. April 2026 | N-PORT |